Diphtheria boosters for adults: Balancing risks

Travel Medicine and Infectious Disease

Volumn 5, Issue 1, 2007, Pages 35-39

  Cameron, Claire ^a   White, Joanne ^a   Power, Deirdre ^a   Crowcroft, Natasha ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Adult vaccination; Tetanus; Vaccine reactions

Indexed keywords

DIPHTHERIA TETANUS VACCINE; DIPHTHERIA VACCINE; TETANUS TOXOID;

ANAMNESIS; ANAPHYLAXIS; ARTICLE; DIPHTHERIA; DRUG EFFICACY; DRUG MEGADOSE; ENDEMIC DISEASE; HEALTH CARE POLICY; HUMAN; INCIDENCE; INFECTION RISK; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE SWELLING; LOW DRUG DOSE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SYMPTOMATOLOGY; TETANUS; TRAVEL; UNITED KINGDOM; VACCINATION; WESTERN EUROPE;

DIPHTHERIA; DIPHTHERIA TOXOID; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; GREAT BRITAIN; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; RISK ASSESSMENT;

EID: 33845223232     PISSN: 14778939     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmaid.2006.02.001     Document Type: Article

References (37)

1. In: Salisbury D.M., and Begg N.T. (Eds). Immunisation against infectious disease (1996), Her Majesty's Stationary Office, London
2. De Benoist A.C., White J.M., Efstratiou A., et al. Imported cutaneous diphtheria, United Kingdom. Emerg Infect Dis 10 3 (2004) 511-513
3. Dittmann S., Wharton M., Vitek C., et al. Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned. J Infect Dis 181 Suppl 1 (2000) S10-S22
4. Vitek C.R., and Wharton M. Diphtheria in the former Soviet Union: re-emergence of pandemic disease. Emerg Infect Dis 4 4 (1998) 539-549
5. Golaz A., Hardy I.R., Strebel P., et al. Epidemic diphtheria in the newly independent states of the former Soviet Union: implications for diphtheria control in the United States. J Infect Dis 81 Suppl 1 (2000) S237-S243
6. Begg N. Manual for the management and control of diphtheria in the European region of the WHO, ICP/EPI 038 (B) WHO Copenhagen. 1994. p. 1-16.
7. Levy-Bruhl D., Pebody R., Veldhuijzen I., Valenciano M., and Osborne K. ESEN: a comparison of vaccination programmes. Part one: diphtheria. Euro Surveill 3 10 (1998) 93-96
8. Department of Health. Chief Medical Officer Update. 2nd May 1994.
9. Department of Health. Replacement of single adsorbed diphtheria vaccine for adults by combined tetanus/low dose diphtheria for adults and adolescents. Update Letter to Immunisation Co-ordinators. 30th July 2003.
10. Department of Health. Immunisation against infectious disease. The 'Green book' chapters on diphtheria, hib, pertussis, polio and tetanus. Department of Health. 2004.
11. Health Protection Agency Diphtheria Notifications. Laboratory isolates of Corynebacterium diphtheriae, deaths and vaccine uptake rates. Accessible at http://www.hpa.org.uk/infections/topics_az/diphtheria/data_death_vaccine.htm
12. Rushdy A.A., White J.M., Ramsay M.E., and Crowcroft N.S. Tetanus in England and Wales, 1984-2000. Epidemiol Infect 130 1 (2003) 71-77
13. CDR. Tetanus in England and Wales 2001-2004. Commun Dis Report 15 (2005) 34
14. Miller E., Rush M., Morgan-Capner P., Hutchinson D., and Hindle L. Immunity to diphtheria in adults in England. BMJ 308 (1994) 598
15. Department of Health Statistical bulletin. NHS immunisation statistics 2003-05. The Department of Health-Pubs and stats Statistics. Accessible at http://www.dh.gov.uk/PublicationsAndStatistics/Statistics/fs/en
16. Mathias R.G., and Schechter M.T. Booster immunisation for diphtheria and tetanus: no evidence of need in adults. Lancet 1 8437 (1985) 1089-1091
17. Mortimer J., Melville-Smith M., and Sheffield F. Diphtheria vaccine for adults. Lancet 2 8517 (1986) 1182-1183
18. Settergren B., Broholm K.A., Norrby S.R., and Christenson B. Diphtheria revaccination of adults. Lancet 1 8532 (1987) 557-558
19. Maple C., Jones C.S., Wall E.C., et al. Immunity to diphtheria and tetanus in England and Wales. Vaccine 19 (2000) 167
20. Edmunds W.J., Pebody R.G., Aggerback H., et al. The sero-epidemiology of diphtheria in Western Europe ESEN Project. European Sero-Epidemiology Network. Epidemiol Infect 126 2 (2000) 331
21. Begg N., and Balraj V. Diphtheria: are we ready for it?. Arch Dis Child 73 6 (1995) 568-572
22. Simonsen O., Kjeldsen K., Vendborg H.A., and Heron I. Revaccination of adults against diphtheria : responses and reactions to different doses of diphtheria toxoid in 30-70-year-old persons with low serum antitoxin levels. Acta Pathol Microbiol Immunol Scand [C] 94 5 (1986) 213-218
23. CDR. Diphtheria acquired during a cruise in the Baltic sea. Commun Dis Report 7 (1997) 219
24. Gardner P. Issues related to the decennial tetanus-diphtheria toxoid booster recommendations in adults. Infect Dis Clin North Am 15 1 (2001) 143-153
25. Centre for Disease Control. Diphtheria, tetanus, pertussis: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991; 40(No.RR10): 1-28.
26. Trollfors B., Taranger J., Lagergard T., et al. A placebo-controlled trial of a pertussis-toxoid vaccine. N Engl J Med 333 16 (1995) 1045-1050
27. Schmitt-Grohe S., Stehr K., Cherry J.D., et al. Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group. Dev Biol Stand 89 (1997) 113-118
28. Long S.S., Deforest A., Smith D.G., Lazaro C., and Wassilak G.F. Longitudinal study of adverse reactions following diphtheria-tetanus-pertussis vaccine in infancy. Pediatrics 85 3 (1990) 294-302
29. Smith G., Norman A., and Banks J. Management of School leavers given a diphtheria and tetanus vaccine intended for children instead of the intended low dose preparation. Commun Dis Report 7 5 (1997)
30. Sidebotham P.D., and Lenton S.W. Incidence of adverse reactions after administration of high dose diphtheria with tetanus vaccine to school leavers: retrospective questionnaire study. BMJ 313 (1996) 533-534
31. Wassilak S.G.F., Roper M.H., Murphy T.V., and Orenstein W.A. Tetanus toxoid. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccines. 4th ed (2004), Philadelphia, Elsevier [Chapter 27]
32. Ramsay M., Joce R., and Whalley J. Adverse events after school leavers received combined tetanus and low dose diphtheria vaccine. Commun Dis Rev 7 5 (1997) 65-67
33. Collier L.H., Polakoff S., and Mortimer J. Reactions and antibody responses to reinforcing doses of adsorbed and plain tetanus vaccines. Lancet (1979) 1364-1368
34. Lloyd J.C., Haber P., Mootrey G.T., Braun M.M., Rhodes P.H., and Chen R.T. Adverse event reporting rates following tetanus-diphtheria and tetanus toxoid vaccinations:data from the Vaccine Adverse Events Reporting System (VAERS), 1991-1997. Vaccine 21 (2003) 3746-3750
35. Jacobs R.L., Lowe R.S., and Lanier B.Q. Adverse reactions to tetanus toxoid. JAMA 247 1 (1982) 40-42
36. Gold M., Goodwin H., Botham S., Burgess M., Nash M., and Kempe A. Re-vaccination of 421 children with a past history of an adverse vaccine reaction in a special immunisation service. Arch Dis Child 83 (2000) 128-131
37. Bohlke K., Davis R.L., Marcy S.M., et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 112 4 (2003) 815-820